161 related articles for article (PubMed ID: 25503325)
1. The RIVUR study: a review of its findings.
Cara-Fuentes G; Gupta N; Garin EH
Pediatr Nephrol; 2015 May; 30(5):703-6. PubMed ID: 25503325
[TBL] [Abstract][Full Text] [Related]
2. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.
Mattoo TK; Chesney RW; Greenfield SP; Hoberman A; Keren R; Mathews R; Gravens-Mueller L; Ivanova A; Carpenter MA; Moxey-Mims M; Majd M; Ziessman HA;
Clin J Am Soc Nephrol; 2016 Jan; 11(1):54-61. PubMed ID: 26555605
[TBL] [Abstract][Full Text] [Related]
3. The RIVUR trial: a factual interpretation of our data.
Mattoo TK; Carpenter MA; Moxey-Mims M; Chesney RW;
Pediatr Nephrol; 2015 May; 30(5):707-12. PubMed ID: 25558811
[TBL] [Abstract][Full Text] [Related]
4. The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes.
Mathews R; Mattoo TK
Adv Chronic Kidney Dis; 2015 Jul; 22(4):325-30. PubMed ID: 26088078
[TBL] [Abstract][Full Text] [Related]
5. Why Does Prevention of Recurrent Urinary Tract Infection not Result in Less Renal Scarring? A Deeper Dive into the RIVUR Trial.
Wang HH; Kurtz M; Logvinenko T; Nelson C
J Urol; 2019 Aug; 202(2):400-405. PubMed ID: 31026216
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.
Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A
Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study.
Keren R; Carpenter MA; Hoberman A; Shaikh N; Matoo TK; Chesney RW; Matthews R; Gerson AC; Greenfield SP; Fivush B; McLurie GA; Rushton HG; Canning D; Nelson CP; Greenbaum L; Bukowski T; Primack W; Sutherland R; Hosking J; Stewart D; Elder J; Moxey-Mims M; Nyberg L
Pediatrics; 2008 Dec; 122 Suppl 5(Suppl 5):S240-50. PubMed ID: 19018048
[TBL] [Abstract][Full Text] [Related]
8. Vesicoureteral reflux and continuous prophylactic antibiotics.
Lee T; Park JM
Investig Clin Urol; 2017 Jun; 58(Suppl 1):S32-S37. PubMed ID: 28612058
[TBL] [Abstract][Full Text] [Related]
9. Are prophylactic antibiotics indicated after a urinary tract infection?
Mattoo TK
Curr Opin Pediatr; 2009 Apr; 21(2):203-6. PubMed ID: 19663037
[TBL] [Abstract][Full Text] [Related]
10. A Reanalysis of the RIVUR Trial Using a Risk Classification System.
Wang ZT; Wehbi E; Alam Y; Khoury A
J Urol; 2018 Jun; 199(6):1608-1614. PubMed ID: 29198997
[TBL] [Abstract][Full Text] [Related]
11. Update on childhood urinary tract infection and vesicoureteral reflux.
Bell LE; Mattoo TK
Semin Nephrol; 2009 Jul; 29(4):349-59. PubMed ID: 19615556
[TBL] [Abstract][Full Text] [Related]
12. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.
Carpenter MA; Hoberman A; Mattoo TK; Mathews R; Keren R; Chesney RW; Moxey-Mims M; Greenfield SP;
Pediatrics; 2013 Jul; 132(1):e34-45. PubMed ID: 23753091
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial prophylaxis for children with vesicoureteral reflux.
; Hoberman A; Greenfield SP; Mattoo TK; Keren R; Mathews R; Pohl HG; Kropp BP; Skoog SJ; Nelson CP; Moxey-Mims M; Chesney RW; Carpenter MA
N Engl J Med; 2014 Jun; 370(25):2367-76. PubMed ID: 24795142
[TBL] [Abstract][Full Text] [Related]
14. Long-term, low-dose prophylaxis against urinary tract infections in young children.
Brandström P; Hansson S
Pediatr Nephrol; 2015 Mar; 30(3):425-32. PubMed ID: 24906665
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for recurrent urinary tract infection in infants with vesicoureteral reflux during prophylactic treatment: effect of delayed contrast passage on voiding cystourethrogram.
Park S; Han JY; Kim KS
Urology; 2011 Jul; 78(1):170-3. PubMed ID: 21316084
[TBL] [Abstract][Full Text] [Related]
16. Positioning irrigation of contrast cystography for diagnosis of occult vesicoureteric reflux: association with technetium-99m dimercaptosuccinic acid scans.
Berger C; Becker T; Koen M; Zeino M; Fitz F; Beheshti M; Wolf-Kohlmeier I; Haim S; Riccabona M
J Pediatr Urol; 2013 Dec; 9(6 Pt A):846-50. PubMed ID: 23219319
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Urinary Tract Infections in Children With Bladder and Bowel Dysfunction.
Shaikh N; Hoberman A; Keren R; Gotman N; Docimo SG; Mathews R; Bhatnagar S; Ivanova A; Mattoo TK; Moxey-Mims M; Carpenter MA; Pohl HG; Greenfield S
Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26647376
[TBL] [Abstract][Full Text] [Related]
18. Bacterial pathogens in first febrile urinary tract infection affect breakthrough infections in infants with vesicoureteral reflux treated with prophylactic antibiotics.
Park S; Song SH; Lee C; Kim JW; Kim KS
Urology; 2013 Jun; 81(6):1342-5. PubMed ID: 23562584
[TBL] [Abstract][Full Text] [Related]
19. Targeted Workup after Initial Febrile Urinary Tract Infection: Using a Novel Machine Learning Model to Identify Children Most Likely to Benefit from Voiding Cystourethrogram.
Advanced Analytics Group of Pediatric Urology and ORC Personalized Medicine Group
J Urol; 2019 Jul; 202(1):144-152. PubMed ID: 30810465
[TBL] [Abstract][Full Text] [Related]
20. Randomized intervention for children with VesicoureReflux (RIVUR) Study: a new look at an old question? Commentary on antimicrobial prophylaxis for children with vesicoureteral reflux.
Afshar K
Urology; 2014 Nov; 84(5):991-2. PubMed ID: 25443892
[No Abstract] [Full Text] [Related]
[Next] [New Search]
